Wealth Alliance Increases Holdings in Xylem Inc. (NYSE:XYL)

Wealth Alliance boosted its position in Xylem Inc. (NYSE:XYLFree Report) by 10.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,855 shares of the industrial products company’s stock after buying an additional 169 shares during the period. Wealth Alliance’s holdings in Xylem were worth $252,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. EverSource Wealth Advisors LLC raised its stake in shares of Xylem by 68.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock valued at $25,000 after buying an additional 77 shares during the last quarter. Blue Trust Inc. raised its position in Xylem by 1,185.7% during the second quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock valued at $35,000 after acquiring an additional 249 shares in the last quarter. FinTrust Capital Advisors LLC raised its position in Xylem by 170.9% during the first quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock valued at $41,000 after acquiring an additional 200 shares in the last quarter. Hazlett Burt & Watson Inc. boosted its position in Xylem by 184.9% in the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock worth $43,000 after purchasing an additional 220 shares in the last quarter. Finally, Redwood Wealth Management Group LLC purchased a new position in shares of Xylem during the 2nd quarter valued at approximately $47,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Trading Down 1.1 %

Shares of XYL stock opened at $134.81 on Friday. Xylem Inc. has a fifty-two week low of $87.59 and a fifty-two week high of $146.08. The firm has a market capitalization of $32.74 billion, a P/E ratio of 47.98, a PEG ratio of 2.34 and a beta of 1.04. The stock’s fifty day moving average is $133.75 and its two-hundred day moving average is $134.09. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.85.

Xylem (NYSE:XYLGet Free Report) last posted its quarterly earnings results on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. The firm had revenue of $2.17 billion for the quarter, compared to analyst estimates of $2.14 billion. Xylem had a net margin of 9.11% and a return on equity of 9.48%. Xylem’s quarterly revenue was up 26.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.98 earnings per share. Research analysts expect that Xylem Inc. will post 4.26 earnings per share for the current fiscal year.

Xylem Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 26th. Investors of record on Thursday, August 29th will be given a dividend of $0.36 per share. The ex-dividend date is Thursday, August 29th. This represents a $1.44 dividend on an annualized basis and a yield of 1.07%. Xylem’s payout ratio is 51.25%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on XYL shares. Robert W. Baird boosted their target price on shares of Xylem from $155.00 to $170.00 and gave the company an “outperform” rating in a research note on Wednesday, July 31st. Stifel Nicolaus upped their price objective on shares of Xylem from $170.00 to $172.00 and gave the stock a “buy” rating in a research report on Wednesday, July 31st. Argus raised their target price on Xylem from $146.00 to $165.00 and gave the company a “buy” rating in a research report on Wednesday, May 29th. Royal Bank of Canada upped their price target on Xylem from $160.00 to $163.00 and gave the stock an “outperform” rating in a report on Wednesday, July 31st. Finally, UBS Group started coverage on Xylem in a report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 price objective on the stock. Five analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $147.54.

Get Our Latest Research Report on Xylem

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Recommended Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.